137160-11-3CCc1cccc(N(C)C(N)=Nc2cccc3ccccc23)c1.ClCKAKVKWRMCAYJD-UHFFFAOYSA-NSee also: Aptiganel (has active moiety).
137160-11-3DTXSID9045762CHEMBL554054Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.
UsesStroke and traumatic brain injury treatment (NMDA ion channel blocker).
UsesCerestat is a Potent and Noncompetitive NMDA receptor antagonist, Significantly reduced ischemic volume in rat focal cerebral ischemia model. (2). It is a neuroprotective, decreases contusion volume, reduced hemispheric swelling and ICP and also increases CPP. (3)
No reaction records under the current filter.
Loading…